Molecular genetics of ependymoma
Yuan Yao1, Stephen C Mack, Michael D Taylor
1Hospital for Sick Children, Toronto, Ontario, Canada.
Abstract:
Brain tumors are the leading cause of cancer death in children, with ependymoma being the third most common and posing a significant clinical burden. Its mechanism of pathogenesis, reliable prognostic indicators, and effective treatments other than surgical resection have all remained elusive. Until recently, ependymoma research was hindered by the small number of tumors available for study, low resolution of cytogenetic techniques, and lack of cell lines and animal models. Ependymoma heterogeneity, which manifests as variations in tumor location, patient age, histological grade, and clinical behavior, together with the observation of a balanced genomic profile in up to 50% of cases, presents additional challenges in understanding the development and progression of this disease. Despite these difficulties, we have made significant headway in the past decade in identifying the genetic alterations and pathways involved in ependymoma tumorigenesis through collaborative efforts and the application of microarray-based genetic (copy number) and transcriptome profiling platforms. Genetic characterization of ependymoma unraveled distinct mRNA-defined subclasses and led to the identification of radial glial cells as its cell type of origin. This review summarizes our current knowledge in the molecular genetics of ependymoma and proposes future research directions necessary to further advance this field.
Insights
Ependymoma, a common pediatric brain tumor, presents challenges due to its heterogeneity. Recent advances in molecular genetics have identified its cell of origin and distinct subclasses, paving the way for future research.
Area of Science:
- Pediatric oncology
- Neuro-oncology
- Cancer genetics
Background:
- Ependymoma is the third most common pediatric brain tumor and a leading cause of cancer death in children.
- Understanding ependymoma pathogenesis, prognosis, and treatment beyond surgery remains a significant clinical challenge.
- Research has been historically limited by small tumor sample sizes, low-resolution genetic techniques, and lack of models.
Purpose of the Study:
- To review current knowledge on the molecular genetics of pediatric ependymoma.
- To highlight recent advancements in identifying genetic alterations and pathways involved in ependymoma tumorigenesis.
- To propose future research directions for understanding and treating ependymoma.
Main Methods:
- Application of microarray-based genetic (copy number) and transcriptome profiling.
- Collaborative efforts to analyze a larger cohort of ependymoma tumors.
- Genetic characterization to identify subclasses and cell of origin.
Main Results:
- Identification of distinct mRNA-defined ependymoma subclasses.
- Determination of radial glial cells as the cell type of origin for ependymoma.
- Significant progress in understanding genetic alterations and pathways driving ependymoma.
Conclusions:
- Recent molecular profiling has greatly advanced the understanding of ependymoma genetics.
- Identification of subclasses and cell of origin provides new avenues for targeted therapies.
- Further research is crucial to translate these findings into improved clinical outcomes for pediatric ependymoma patients.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...